Fineline Cube

Follow:
14778 Articles
GSK plc Expands Pipeline with Rgenta Therapeutics Partnership for RNA-Targeted Splice Modulators
CompanyDeals

GSK plc Expands Pipeline with Rgenta Therapeutics Partnership for RNA-Targeted Splice Modulators

Merus N.V. Receives FDA Approval for Bizengri for NRG1+ Pancreatic and Lung Cancers
CompanyDrug

Merus N.V. Receives FDA Approval for Bizengri for NRG1+ Pancreatic and Lung Cancers

Ipsen's Bylvay Receives NMPA Clearance for Treating Itching in PFIC Patients in China
CompanyDrug

Ipsen’s Bylvay Receives NMPA Clearance for Treating Itching in PFIC Patients in China

Tasly Pharma Receives NMPA Approval for Generic Lioresal (Baclofen) Oral Solution
CompanyDrug

Tasly Pharma Receives NMPA Approval for Generic Lioresal (Baclofen) Oral Solution

Humanwell Healthcare's Recombinant Plasmid Hepatocyte Growth Factor Injection Accepted for NMPA Review
CompanyDrug

Humanwell Healthcare’s Recombinant Plasmid Hepatocyte Growth Factor Injection Accepted for NMPA Review

Haisco Pharmaceutical's HSK46575 Receives NMPA Approval for Prostate Cancer Clinical Trial
CompanyDrug

Haisco Pharmaceutical’s HSK46575 Receives NMPA Approval for Prostate Cancer Clinical Trial

Sichuan Kelun-Biotech's SKB500 Receives NMPA Clinical Clearance for Solid Tumor Treatment
CompanyDrug

Sichuan Kelun-Biotech’s SKB500 Receives NMPA Clinical Clearance for Solid Tumor Treatment

Cinclus Pharma's Linaprazan for GERD Receives NMPA Marketing Approval
CompanyDrug

Cinclus Pharma’s Linaprazan for GERD Receives NMPA Marketing Approval

CSPC Pharmaceutical's CRB-701 Earns FDA Fast Track Designation for Cervical Cancer Treatment
Company

CSPC Pharmaceutical’s CRB-701 Earns FDA Fast Track Designation for Cervical Cancer Treatment

Sisram Medical's Alma Harmony and Alma Hybrid Receive EU Medical Device Certification
CompanyMedical Device

Sisram Medical’s Alma Harmony and Alma Hybrid Receive EU Medical Device Certification

Shanghai Henlius Biotech's HLX11 Biosimilar Accepted for Review by China's CDE
CompanyDrug

Shanghai Henlius Biotech’s HLX11 Biosimilar Accepted for Review by China’s CDE

Wuhan Kaideweisi Biotechnology Secures Series B Funding for Gynecologic Oncology Expansion
CompanyDeals

Wuhan Kaideweisi Biotechnology Secures Series B Funding for Gynecologic Oncology Expansion